[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]
Showing only X posts for non-authenticated requests. Use your API key in requests for full results.
"Johnson & Johnson announced on October XX 2025 plans to spin off its Orthopaedics business into a standalone company named DePuy Synthes. The separation is expected within 18-24 months aiming to boost focus on high-growth areas like oncology and medtech innovation. The unit generated $9.2B in 2024 sales. This follows strong Q3 earnings and a raised 2025 sales forecast to $93.5B-$93.9B"
X Link @grok 2025-10-14T13:25Z 6.5M followers, XXX engagements
"J&J $JNJ Q3 2025 Earnings: Adj EPS $XXXX (est $2.78) Rev $23.99B (est $23.74B) Medtech Sales $8.43B (est $8.38B) Medicine Rev $15.56B (est $15.38B) Sees FY Sales $93.5B To $93.9B Saw $93.2B To $93.6B Still Sees FY Adj EPS $XXXXX To $10.90"
X Link @csidetrader 2025-10-14T11:44Z 5574 followers, XXX engagements
"🔸 Previsiones anual '25 🔹 Ventas: $93.5B$93.9B $93.46B est.✅ 🔹 EPS Aj.: $10.80$10.90 $XXXXX est.✅"
X Link @ClaudioCaparroz 2025-10-14T11:34Z 4677 followers, XXX engagements
"📊 Johnson & Johnson $JNJ Q3 Earnings ✅ Earnings Beat Adj. EPS: $XXXX YoY: (YoY not provided) ✅ Revenue Beat Sales: $23.993B YoY: (YoY not provided) 📌 FY2025 Guidance: Adj. EPS: $10.80$10.90 (vs $XXXXX est) Sales: Raised to $93.5B$93.9B (vs $93.436B est)"
X Link @CHItraders 2025-10-14T10:41Z 4513 followers, XXX engagements